0001567619-19-001865.txt : 20190129
0001567619-19-001865.hdr.sgml : 20190129
20190129190003
ACCESSION NUMBER: 0001567619-19-001865
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190125
FILED AS OF DATE: 20190129
DATE AS OF CHANGE: 20190129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HUMPHREY RACHEL
CENTRAL INDEX KEY: 0001579781
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37587
FILM NUMBER: 19549950
MAIL ADDRESS:
STREET 1: C/O MIRATI THERAPEUTICS INC.
STREET 2: 4660 LA JOLLA VILLAGE DRIVE, SUITE 500
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytomX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001501989
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273521219
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650.515.3185
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc1.xml
FORM 4
X0306
4
2019-01-25
0
0001501989
CytomX Therapeutics, Inc.
CTMX
0001579781
HUMPHREY RACHEL
151 OYSTER POINT BLVD.
SUITE 400
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
16.85
2019-01-25
4
A
0
90000
0.00
A
2029-01-24
Common Stock
90000
90000
D
1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2019 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.
/s/ Debanjan Ray, as Attorney-in-Fact for Rachel Humphrey
2019-01-29